Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 USD | +10.62% | +4.17% | +13.64% |
Apr. 15 | Cell MedX Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Mar. 12 | Cell MedX Corp. announced that it has received $0.075 million in funding | CI |
Business Summary
Number of employees: 1
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Monthly Subscriptions
58.8
%
| 0 | 60.6 % | 0 | 58.8 % | -55.85% |
eBalance Devices
41.2
%
| 0 | 39.4 % | 0 | 41.2 % | -52.33% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -54.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | Dec. 11 |
Yanika Silina
DFI | Director of Finance/CFO | 46 | 14-11-23 |
George Adams
CHM | Chairman | 76 | 18-03-22 |
Joao da Costa
BRD | Director/Board Member | 59 | 20-06-07 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 22-04-26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | Dec. 11 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 22-04-26 |
Joao da Costa
BRD | Director/Board Member | 59 | 20-06-07 |
George Adams
CHM | Chairman | 76 | 18-03-22 |
Amir Vahabzadeh
BRD | Director/Board Member | 55 | Dec. 11 |
Yanika Silina
DFI | Director of Finance/CFO | 46 | 14-11-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 297,236,373 | 60,447,694 ( 20.34 %) | 0 | 20.34 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+13.64% | 7.43M | |
+23.50% | 45.01B | |
+47.19% | 40.96B | |
-5.16% | 38.62B | |
+36.37% | 32.6B | |
-7.79% | 27.49B | |
+18.06% | 27.17B | |
+47.29% | 14.61B | |
+41.91% | 12.95B | |
-1.02% | 11.36B |
- Stock Market
- Equities
- CMXC Stock
- Company Cell MedX Corp.